产品展示
Nephilatoxin NPTX-9
点击次数:200发布时间:2012/8/8 8:50:54
更新日期:2013/4/12 9:19:39
所 在 地:中国大陆
产品型号:114355-42-9
优质供应
详细内容
N-0102 | Nectofibrin Hexapeptide (rat) | C32H47N7O9 | 673.77 | H-Trp-Thr-Val-Pro-Thr-Ala-OH | |
N-0201 | α-Neoendorphin Prodynorphin (175-184) (human, porcine) | C60H89N15O13 | 1228.46 | H-Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-Lys-OH | |
N-0202 | α-Neoendorphin (1-8) | C49H70N12O11 | 1003.17 | H-Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-OH | |
N-0203 | β-Neoendorphin Prodynorphin (175-183) (human, porcine) | C54H77N13O12 | 1100.29 | H-Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-OH | |
N-0301 | Nephilatoxin NPTX-9 | C30H49N11O5 | 643.79 | 114355-42-9 | Indol-3-yl-acetyl-Asn-1,5-diaminopentane-retro-Orn-Arg-H |
N-0302 | Nephilatoxin NPTX-11 | C24H37N7O4 | 487.60 | 119613-54-6 | Indol-3-yl-acetyl-Asn-1,5-diaminopentane-retro-Orn-H |
N-0401 | Nesfatin-1 (human) Nucleobindin-2 (25-106) (human), NUCB2 (25-106) (human), DNA-Binding Protein NEFA (25-106) (human), Gastric Cancer Antigen Zg4 (25-106) (human) | C427H691N113O134 | 9551.87 | H-Val-Pro-Ile-Asp-Ile-Asp-Lys-Thr-Lys-Val-Gln-Asn-Ile-His-Pro-Val-Glu-Ser-Ala-Lys-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Asp-Val-Leu-Glu-Thr-Asp-Lys-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Lys-Ser-Gly-Arg-Leu-Ser-Lys-Glu-Leu-Asp-Leu-Val-Ser-His-His-Val-Arg-Thr-Lys-Leu-Asp-Glu-Leu-OH Trifluoroacetate salt | |
N-0402 | Nesfatin-1 (mouse) Nucleobindin-2 (25-106) (mouse), NUCB2 (25-106) (mouse), DNA-Binding Protein NEFA (25-106) (mouse) | C424H683N117O137 | 9611.79 | H-Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Thr-Glu-Pro-Val-Glu-Asn-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu-OH Trifluoroacetate salt | |
N-0403 | Nesfatin-1 (rat) Nucleobindin-2 (1-82) (rat), NUCB2 (1-82) (rat), DNA-Binding Protein NEFA (1-82) (rat) | C424H684N116O136 | 9582.80 | H-Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu-OH Trifluoroacetate salt | |
N-0501 | Neuroendocrine Regulatory Peptide-1 (human) NERP-1 (human) | C113H192N36O39 | 2678.99 | 954420-50-9 | H-Arg-Pro-Glu-Ser-Ala-Leu-Leu-Gly-Gly-Ser-Glu-Ala-Gly-Glu-Arg-Leu-Leu-Gln-Gln-Gly-Leu-Ala-Gln-Val-Glu-Ala-NH2 Trifluoroacetate salt |
N-0502 | Neuroendocrine Regulatory Peptide-1 (rat) NERP-1 (rat) | C110H180N32O38 | 2558.83 | 954420-51-0 | H-Leu-Glu-Gly-Ser-Phe-Leu-Gly-Gly-Ser-Glu-Ala-Gly-Glu-Arg-Leu-Leu-Gln-Gln-Gly-Leu-Ala-Gln-Val-Glu-Ala-NH2 Trifluoroacetate salt |
N-0503 | Neuroendocrine Regulatory Peptide-2 (human) NERP-2 (human) | C173H288N56O57 | 4064.53 | Pyr-Ala-Glu-Ala-Thr-Arg-Gln-Ala-Ala-Ala-Gln-Glu-Glu-Arg-Leu-Ala-Asp-Leu-Ala-Ser-Asp-Leu-Leu-Leu-Gln-Tyr-Leu-Leu-Gln-Gly-Gly-Ala-Arg-Gln-Arg-Gly-Leu-Gly-NH2 Trifluoroacetate salt | |
N-0504 | Neuroendocrine Regulatory Peptide-2 (rat) NERP-2 (rat) | C175H290N56O59 | 4122.57 | Pyr-Ala-Glu-Ala-Thr-Arg-Gln-Ala-Ala-Ala-Gln-Glu-Glu-Arg-Leu-Ala-Asp-Leu-Ala-Ser-Asp-Leu-Leu-Leu-Gln-Tyr-Leu-Leu-Gln-Gly-Gly-Ala-Arg-Gln-Arg-Asp-Leu-Gly-NH2 Trifluoroacetate salt | |
N-0601 | C39H51N9O10 | 805.89 | 129809-09-2 | Ac-Leu-Asp-Gln-Trp-Phe-Gly-NH2 | |
N-0602 | C47H65N9O9 | 900.08 | 141663-86-7 | Boc-Ala-Ala-D-Trp-Phe-D-Pro-Pro-Nle-NH2 | |
N-0603 | GR 94800 | C49H61N9O8 | 904.08 | Bz-Ala-Ala-D-Trp-Phe-D-Pro-Pro-Nle-NH2 | |
N-0604 | C38H50N8O7S | 762.93 | 125989-12-0 | Cyclo(-Gln-Trp-Phe-Gly-Leu-Met) | |
N-0605 | BIM-23127 | C62H71N11O9S2 | 1178.45 | 179188-73-9 | H-D-2-Nal-Cys-Tyr-D-Trp-Orn-Val-Cys-2-Nal-NH2 (Disulfide bond) |
N-0606 | Neurokinin A NKA, Substance K, Neurokinin α, Neuromedin L | C50H80N14O14S | 1133.34 | 86933-74-6 | H-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 Trifluoroacetate salt |
N-0606-2 | (Tyr0)-Neurokinin A | C59H89N15O16S | 1296.51 | H-Tyr-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | |
N-0607 | Neurokinin A (4-10) | C34H54N8O10S | 766.92 | 97559-35-8 | H-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 |
N-0607-2 | (β-Ala8)-Neurokinin A (4-10) | C35H56N8O10S | 780.94 | 127633-71-0 | H-Asp-Ser-Phe-Val-β-Ala-Leu-Met-NH2 |
N-0607-3 | (Nle10)-Neurokinin A (4-10) | C35H56N8O10 | 748.88 | 110863-33-7 | H-Asp-Ser-Phe-Val-Gly-Leu-Nle-NH2 |
N-0607-4 | (Trp7,β-Ala8)-Neurokinin A (4-10) | C41H57N9O10S | 868.02 | H-Asp-Ser-Phe-Trp-β-Ala-Leu-Met-NH2 | |
N-0607-5 | (Tyr5,D-Trp6·8·9,Arg-NH210)-Neurokinin A (4-10) | C57H68N14O10 | 1109.26 | H-Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Arg-NH2 | |
N-0607-6 | (Tyr5,D-Trp6·8·9,Lys-NH210)-Neurokinin A (4-10) MEN 10376 | C57H68N12O10 | 1081.24 | 135306-85-3 | H-Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2 |
N-0608 | Neurokinin B NKB | C55H79N13O14S2 | 1210.44 | 86933-75-7 | H-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 Trifluoroacetate salt |
N-0608-2 | Biotinyl-Neurokinin B Biotinyl-Neurokinin β, Biotinyl-Neuromedin K, Biotinyl-NKB | C65H93N15O16S3 | 1436.74 | 198328-30-2 | Biotinyl-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 |
N-0608-3 | (N-Me-Phe7)-Neurokinin B | C60H81N13O14S2 | 1272.51 | 110880-53-0 | H-Asp-Met-His-Asp-Phe-Phe-N-Me-Phe-Gly-Leu-Met-NH2 Trifluoroacetate salt |
N-0608-4 | (Pro7)-Neurokinin B | C55H77N13O14S2 | 1208.43 | 120814-48-4 | H-Asp-Met-His-Asp-Phe-Phe-Pro-Gly-Leu-Met-NH2 |
N-0608-5 | (D-Pro2,D-Trp6·8,Nle10)-Neurokinin B | C67H87N15O14 | 1326.52 | 109212-72-8 | H-Asp-D-Pro-His-Asp-Phe-D-Trp-Val-D-Trp-Leu-Nle-NH2 |
N-0609 | Neuromedin B | C52H73N15O12S | 1132.31 | 87096-84-2 | H-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 Trifluoroacetate salt |
N-0610 | Neuromedin N | C38H63N7O8 | 745.96 | 92169-45-4 | H-Lys-Ile-Pro-Tyr-Ile-Leu-OH |
N-0611 | Neuromedin S (human) NMS (human) | C173H265N53O44 | 3791.34 | H-Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
N-0611-2 | Biotinyl-Neuromedin S (human) Biotinyl-NMS (human) | C183H279N55O46S | 4017.64 | Biotinyl-Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 Trifluoroacetate salt | |
N-0612 | Prepro-Neuromedin S (70-103) (human) Prepro-NMS (70-103) (human) | C180H271N49O44S | 3857.50 | H-Phe-Leu-Phe-His-Tyr-Ser-Arg-Thr-Gln-Glu-Ala-Thr-His-Pro-Val-Lys-Thr-Gly-Phe-Pro-Pro-Val-His-Pro-Leu-Met-His-Leu-Ala-Ala-Lys-Leu-Ala-Asn-OH | |
N-0613 | Neuromedin S (rat) NMS (rat) | C193H307N57O49S | 4241.98 | H-Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
N-0614 | Biotinyl-Neuromedin S (rat) Biotinyl-NMS (rat) | C203H321N59O51S | 4436.22 | Biotinyl-Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 Trifluoroacetate salt | |
N-0615-2 | (Leu116)-Prepro-Neuromedin U (104-136) (human) Prepro-NMU (104-136) (human), (Leu116)-Prepro-NMU (104-136) (human) | C177H276N46O45 | 3768.42 | H-Phe-Leu-Phe-His-Tyr-Ser-Lys-Thr-Gln-Lys-Leu-Gly-Leu-Ser-Asn-Val-Val-Ser-Ser-Val-Val-His-Pro-Leu-Leu-Gln-Leu-Val-Pro-His-Leu-His-Glu-OH Trifluoroacetate salt | |
N-0615 | Prepro-Neuromedin U (104-136) (human) Prepro-NMU (104-136) (human) | C177H277N47O45 | 3783.44 | H-Phe-Leu-Phe-His-Tyr-Ser-Lys-Thr-Gln-Lys-Leu-Gly-Lys-Ser-Asn-Val-Val-Ser-Ser-Val-Val-His-Pro-Leu-Leu-Gln-Leu-Val-Pro-His-Leu-His-Glu-OH Trifluoroacetate salt | |
N-0616 | Neuromedin U-8 (porcine) | C54H78N16O10 | 1111.32 | 98395-75-6 | H-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 Trifluoroacetate salt |